Annuncio pubblicitario
Italia markets closed

  • FTSE MIB

    34.657,35
    +318,03 (+0,93%)
     

  • Dow Jones

    39.512,84
    +125,08 (+0,32%)
     

  • Nasdaq

    16.340,87
    -5,40 (-0,03%)
     

  • Nikkei 225

    38.229,11
    +155,13 (+0,41%)
     

  • Petrolio

    78,20
    -1,06 (-1,34%)
     

  • Bitcoin EUR

    56.355,79
    -1.701,57 (-2,93%)
     

  • CMC Crypto 200

    1.302,78
    -55,23 (-4,07%)
     

  • Oro

    2.366,90
    +26,60 (+1,14%)
     

  • EUR/USD

    1,0772
    -0,0012 (-0,11%)
     

  • S&P 500

    5.222,68
    +8,60 (+0,16%)
     

  • HANG SENG

    18.963,68
    +425,87 (+2,30%)
     

  • Euro Stoxx 50

    5.085,08
    +30,67 (+0,61%)
     

  • EUR/GBP

    0,8601
    -0,0007 (-0,08%)
     

  • EUR/CHF

    0,9760
    -0,0005 (-0,05%)
     

  • EUR/CAD

    1,4718
    -0,0026 (-0,17%)
     

Stereotaxis to Report Second Quarter Financial Results on August 9, 2022

Stereotaxis, Inc.
·2 minuto per la lettura
Stereotaxis, Inc.
Stereotaxis, Inc.

ST. LOUIS, July 19, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2022 second quarter on Tuesday, August 9, 2022 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. ET that day to discuss the Company’s results and corporate developments.

What:  

Stereotaxis second quarter 2022 financial results conference call

 

 

When:

Tuesday, August 9, 2022 at 10:00 a.m. ET (7:00 a.m. PT)

 

 

Dial In Number:

To access the live call, dial 888-394-8218 (US and Canada) or 1-856-344-9221 (International) and give the participant pass code 9211068.

 

 

Webcast:

To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/

 

 

Call Replay:

A phone replay of the call will be available for one month beginning approximately two hours following the end of the call. To request access for a replay of the conference call, please click here.

About Stereotaxis
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 100,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com

Investor Contacts:
David L. Fischel
Chairman and Chief Executive Officer

Media Contact:
Bethanne Schluter
Director, Marketing & Communications

 

 

Kimberly Peery
Chief Financial Officer

 

 

 

314-678-6100
Investors@Stereotaxis.com